UPDATE: Acorda Therapeutics (ACOR) Said to Attract Takeover Interest from Biogen (BIIB), UCB - Bloomberg

January 19, 2018 6:13 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - January 19, 2018 6:16 AM EST)

Acorda Therapeutics (NASDAQ: ACOR) has attracted takeover interest from Biogen (Nasdaq: BIIB) and Belgium's UCB, according to Bloomberg, citing people familiar with the matter. Talks are ongoing and other potential bidders may emerge. The company has also drawn interest from Asian drugmakers.

The company could fetch more than $1.3 billion in a sale.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk